EC strikes deal for supply of JNJ-78436735 Covid-19 vaccine candidate
Johnson & Johnson (J&J) said that the European Commission (EC) has approved an advance purchase agreement for securing 200 million doses of the JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S) developed by its subsidiary Janssen Pharmaceutical Companies. Currently, the JNJ-78436735 vaccine candidate is being evaluated in the phase 3 ENSEMBLE Covid-19 vaccine trial across certain countries. The […]
ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), which is being developed by its subsidiary – Janssen Pharmaceutical Companies. The US healthcare giant said that the ENSEMBLE vaccine trial has been initiated following positive interim results from its […]
Continue reading …
Business News Today
- Lendesk acquires digital mortgage origination provider Finmo Financial
- B&G Foods to acquire Crisco shortening brand from Smucker’s for $550m
- Carlyle Group acquires 27 distribution logistics assets in France and Germany
- LubeZone acquires mobile truck services provider All Star Truck Repair
- Diageo to acquire Chase Original Potato Vodka owner Chase Distillery
- Coca-Cola European Partners plans to acquire Coca-Cola Amatil for $6.6bn
- Verisem acquires new vegetable seed processing facility in Warden, WA
- GrubMarket acquires Los Angeles-based produce provider Best Fresh Produce
- Danone’s Nutricia acquires special needs business Real Food Blends
- Bluestar Alliance wins stalking horse bid for tween fashion brand Justice
